Cybin is trading 7.07% higher in pre-market at $13.48, versus its September 28 close of $12.59; no confirmed company-specific catalyst was identified. - Available search results showed no clear company-specific announcement dated September 29. - Recent coverage highlighted upcoming fourth-quarter Phase III HLP003 results, but this is prior context, not a confirmed new catalyst. - Broader indices are only modestly higher; the available evidence does not establish a market-wide explanation.